Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cherian Verghese

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Journal of Therapeutics|July 22, 2004
Acute reversible heart failure with highly active antiretroviral therapyMohit Srivastava, Cherian Verghese, Douglas Sepkowitz
Journal of Global Oncology|September 23, 2018
Screening for Lung Cancer Has Limited Effectiveness Globally and Distracts From Much Needed Efforts to Reduce the Critical Worldwide Prevalence of Smoking and Related Morbidity and MortalityCherian Verghese, Cristina Redko, Brian Fink
American Journal of Therapeutics|January 25, 2020
Atorvastatin-Induced EosinophiliaAnkur P Choubey, Ali Alqahtani, Cherian Verghese
American Journal of Therapeutics|November 22, 2014
Primary Evan Syndrome With Disseminated Intravascular Coagulation Suggests Progressive Immune Dysregulation and Early Immunosuppressive Intervention is Key to Improving OutcomesNauman Siddiqui, Anis Toumeh, Yongsook Yoon, et al.
The American Journal of the Medical Sciences|July 8, 2018
Ischemic Stroke After PlasmapheresisHisham Salahuddin, Ajaz Ahmad Sheikh, Sharmeen Hussaini, et al.
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|March 27, 2010
A 28-year-old man with leukocytosis and anemiaShravan K Narmala, Kishore K Gandla, Cherian Verghese, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|October 31, 2022
IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular MarkersCherian Verghese, Weihong Li, Nanuli Gvazava, et al.
Journal of Hematology|December 19, 2024
Sequential Use of Prednisolone and Cyclosporine Is Effective in the Management of Immunotherapy-Related Hemolytic AnemiaCherian Verghese, Niravkumar Brahmbhatt, Ghulam Ghous, et al.
American Journal of Clinical Oncology|February 16, 2026
Surveillance Strategies in Follicular Non-Hodgkin's Lymphoma's Using Molecular and Genetic Markers Improve Cost-efficiencies Over Routine Imaging StudiesCherian Verghese, Kapil Meleveedu, Urja Nagadia, et al.
Cureus|October 18, 2021
Increased Incidence of Thrombotic Complications With Non-small Cell Lung Cancer Necessitates Consideration of Prophylactic Anticoagulation in Young IndividualsArindam Bagchi, Mohammad Saud Khan, Arti Saraswat, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Journal of Therapeutics|July 22, 2004
Acute reversible heart failure with highly active antiretroviral therapyMohit Srivastava, Cherian Verghese, Douglas Sepkowitz
Journal of Global Oncology|September 23, 2018
Screening for Lung Cancer Has Limited Effectiveness Globally and Distracts From Much Needed Efforts to Reduce the Critical Worldwide Prevalence of Smoking and Related Morbidity and MortalityCherian Verghese, Cristina Redko, Brian Fink
American Journal of Therapeutics|January 25, 2020
Atorvastatin-Induced EosinophiliaAnkur P Choubey, Ali Alqahtani, Cherian Verghese
American Journal of Therapeutics|November 22, 2014
Primary Evan Syndrome With Disseminated Intravascular Coagulation Suggests Progressive Immune Dysregulation and Early Immunosuppressive Intervention is Key to Improving OutcomesNauman Siddiqui, Anis Toumeh, Yongsook Yoon, et al.
The American Journal of the Medical Sciences|July 8, 2018
Ischemic Stroke After PlasmapheresisHisham Salahuddin, Ajaz Ahmad Sheikh, Sharmeen Hussaini, et al.
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|March 27, 2010
A 28-year-old man with leukocytosis and anemiaShravan K Narmala, Kishore K Gandla, Cherian Verghese, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|October 31, 2022
IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular MarkersCherian Verghese, Weihong Li, Nanuli Gvazava, et al.
Journal of Hematology|December 19, 2024
Sequential Use of Prednisolone and Cyclosporine Is Effective in the Management of Immunotherapy-Related Hemolytic AnemiaCherian Verghese, Niravkumar Brahmbhatt, Ghulam Ghous, et al.
American Journal of Clinical Oncology|February 16, 2026
Surveillance Strategies in Follicular Non-Hodgkin's Lymphoma's Using Molecular and Genetic Markers Improve Cost-efficiencies Over Routine Imaging StudiesCherian Verghese, Kapil Meleveedu, Urja Nagadia, et al.
Cureus|October 18, 2021
Increased Incidence of Thrombotic Complications With Non-small Cell Lung Cancer Necessitates Consideration of Prophylactic Anticoagulation in Young IndividualsArindam Bagchi, Mohammad Saud Khan, Arti Saraswat, et al.
Pageof 2